Literature DB >> 17034898

Priority setting at the micro-, meso- and macro-levels in Canada, Norway and Uganda.

Lydia Kapiriri1, Ole Frithjof Norheim, Douglas K Martin.   

Abstract

UNLABELLED: The objectives of this study were (1) to describe the process of healthcare priority setting in Ontario-Canada, Norway and Uganda at the three levels of decision-making; (2) to evaluate the description using the framework for fair priority setting, accountability for reasonableness; so as to identify lessons of good practices.
METHODS: We carried out case studies involving key informant interviews, with 184 health practitioners and health planners from the macro-level, meso-level and micro-level from Canada-Ontario, Norway and Uganda (selected by virtue of their varying experiences in priority setting). Interviews were audio-recorded, transcribed and analyzed using a modified thematic approach. The descriptions were evaluated against the four conditions of "accountability for reasonableness", relevance, publicity, revisions and enforcement. Areas of adherence to these conditions were identified as lessons of good practices; areas of non-adherence were identified as opportunities for improvement.
RESULTS: (i) DESCRIPTION: at the macro-level, in all three countries, cabinet makes most of the macro-level resource allocation decisions and they are influenced by politics, public pressure, and advocacy. Decisions within the ministries of health are based on objective formulae and evidence. International priorities influenced decisions in Uganda. Some priority-setting reasons are publicized through circulars, printed documents and the Internet in Canada and Norway. At the meso-level, hospital priority-setting decisions were made by the hospital managers and were based on national priorities, guidelines, and evidence. Hospital departments that handle emergencies, such as surgery, were prioritized. Some of the reasons are available on the hospital intranet or presented at meetings. Micro-level practitioners considered medical and social worth criteria. These reasons are not publicized. Many practitioners lacked knowledge of the macro- and meso-level priority-setting processes. (ii) Evaluation-relevance: medical evidence and economic criteria were thought to be relevant, but lobbying was thought to be irrelevant. Publicity: all cases lacked clear and effective mechanisms for publicity. REVISIONS: formal mechanisms, following the planning hierarchy, were considered less effective, informal political mechanisms were considered more effective. Canada and Norway had patients' relations officers to deal with patients' dissensions; however, revisions were more difficult in Uganda. Enforcement: leadership for ensuring decision-making fairness was not apparent.
CONCLUSIONS: The different levels of priority setting in the three countries fulfilled varying conditions of accountability for reasonableness, none satisfied all the four conditions. To improve, decision makers at the three levels in all three cases should engage frontline practitioners, develop more effectively publicized reasons, and develop formal mechanisms for challenging and revising decisions.

Entities:  

Mesh:

Year:  2006        PMID: 17034898     DOI: 10.1016/j.healthpol.2006.09.001

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  38 in total

1.  Allocating funds for HIV/AIDS: a descriptive study of KwaDukuza, South Africa.

Authors:  Arielle Lasry; Michael W Carter; Gregory S Zaric
Journal:  Health Policy Plan       Date:  2010-06-15       Impact factor: 3.344

Review 2.  Setting Healthcare Priorities at the Macro and Meso Levels: A Framework for Evaluation.

Authors:  Edwine W Barasa; Sassy Molyneux; Mike English; Susan Cleary
Journal:  Int J Health Policy Manag       Date:  2015-09-16

3.  Successful priority setting in low and middle income countries: a framework for evaluation.

Authors:  Lydia Kapiriri; Douglas K Martin
Journal:  Health Care Anal       Date:  2009-03-14

4.  Who is in and who is out? A qualitative analysis of stakeholder participation in priority setting for health in three districts in Uganda.

Authors:  S Donya Razavi; Lydia Kapiriri; Julia Abelson; Michael Wilson
Journal:  Health Policy Plan       Date:  2019-06-01       Impact factor: 3.344

Review 5.  The evolution of public health ethics frameworks: systematic review of moral values and norms in public health policy.

Authors:  Mahmoud Abbasi; Reza Majdzadeh; Alireza Zali; Abbas Karimi; Forouzan Akrami
Journal:  Med Health Care Philos       Date:  2018-09

6.  Ethical Dilemmas in Protecting Susceptible Subpopulations From Environmental Health Risks: Liberty, Utility, Fairness, and Accountability for Reasonableness.

Authors:  David B Resnik; D Robert MacDougall; Elise M Smith
Journal:  Am J Bioeth       Date:  2018-03       Impact factor: 11.229

Review 7.  Making Smarter Decisions Faster: Systems Engineering to Improve the Global Public Health Response to HIV.

Authors:  Anjuli D Wagner; Jonny Crocker; Shan Liu; Peter Cherutich; Sarah Gimbel; Quinhas Fernandes; Melissa Mugambi; Kristjana Ásbjörnsdóttir; Sarah Masyuko; Bradley H Wagenaar; Ruth Nduati; Kenneth Sherr
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.071

8.  The unfunded priorities: an evaluation of priority setting for noncommunicable disease control in Uganda.

Authors:  Beverley M Essue; Lydia Kapiriri
Journal:  Global Health       Date:  2018-02-20       Impact factor: 4.185

9.  Based Real Time Remote Health Monitoring Systems: A Review on Patients Prioritization and Related "Big Data" Using Body Sensors information and Communication Technology.

Authors:  Naser Kalid; A A Zaidan; B B Zaidan; Omar H Salman; M Hashim; H Muzammil
Journal:  J Med Syst       Date:  2017-12-29       Impact factor: 4.460

10.  SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies.

Authors:  Andrew D Oxman; John N Lavis; Atle Fretheim; Simon Lewin
Journal:  Health Res Policy Syst       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.